Bryan Garnier - EUTELSAT (ETL) ... Bryan, Garnier Co Technology Daily | ETL, SESFd, SOP, TEF, TELCO, SEMIS

Report

Bryan Garnier

TMT Team

Bryan, Garnier & Co Technology Daily | ETL, SESFd, SOP, TEF, TELCO, SEMIS

21/03/2023 1 EN

Underlyings

EUTELSAT

See profile

Orange

See profile

SES

See profile

Luxembourg

Sopra Steria Group SA

Sopra Steria Group is a global player in IT services, with operations in consulting, software development, and integration. In addition to France, Co. operates in the United Kingdom, Spain, Italy, Switzerland, Germany, and Belgium, assisting its clients in managing the transformation of their businesses and information systems. Co. divides its operation into three categories: Consulting, Systems and Solutions Integration, and Software Development; which it spreads among eight major verticals: Financial Services, Insurance and Social Welfare, Public Sector, Telecom Operators, Aerospace and Defense, Energy, Transport and Courier Services, and Retail.

See profile

FR0000050809 Euronext Paris France

Telefonica S.A. ADS

See profile

US8793822086 Mexican Stock Exchange Spain

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

TMT Team

Other Reports on these Companies

Bryan Garnier

SES: a strong Q4 in line with last week's trading update

Q4 results exceeded css on both revenue (+2% vs. css) and margin (+460bps vs. css), although this was largely anticipated following last week’s trading update. In our view, the strong operational performance was driven primarily by stronger-than-expected Networks and disciplined cost control, with

15h / 35m 15h / 35m 1 EN

BusinessWire

Sopra Steria Group : Déclaration du nombre d’actions et de droits de vote au 31 janvier 2025

PARIS--(BUSINESS WIRE)-- Regulatory News: Conformément à l’article L.233-8 II du code de commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers, Sopra Steria Group (Paris:SOP) informe ses actionnaires que le nombre d’actions et de droits de vote existants au 31/05/2024 sont : Nombre d’actions : 20 547 701 Nombre de droits de vote théoriques : 26 551 735 Nombre de droits de vote exerçables : 25 585 219 Consultez la version source sur businesswire.com :

February 25, 2025 February 25, 2025 1 FR

Bryan Garnier

SES: defying Moody’s downgrade with a FY24 pre-release

SES issued a market update ahead of its FY24 results on 26th February 2025. The update follows Moody’s downgrade of SES’s outlook from stable to negative, with its credit rating remaining just one notch above non-investment grade. SES now expects adj. EBITDA to exceed the guidance range (EUR950–1,0

February 19, 2025 February 19, 2025 1 EN

Nel: FY24 results, poor visibility FY25

NEL has reported FY24 revenues below consensus expectations at NOK1.39bn (+3% YoY, -3% vs cons. at NOK1.43bn), but a slightly better than expected EBITDA loss of -NOK173m (+9% vs cons. at -NOK191m), vs -NOK272m in FY23. Q4 dynamics followed a fairly similar pace to previous quarters, supported by a

15h / 21m 15h / 21m 1 EN

Antoine Lebourgeois

Antoine Lebourgeois

SES: a strong Q4 in line with last week's trading update

15h / 35m 15h / 35m 1 EN

Oscar Haffen Lamm

Oscar Haffen Lamm

Medincell: Uzedy's sNDA for label extension into BP-I accepted by the FDA

Teva announced yesterday the sNDA for Uzedy for the maintenance treatment of Bipolar I Disorder (BP-I) in adults has been accepted for filing by the FDA, which if approved would add approx. a 310k addressable patient pool, represented by the same prescribers as in Schizophrenia. As a benchmark, Abl

15h / 50m 15h / 50m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Bryan, Garnier & Co Technology Daily | ETL, SESFd, SOP, TEF, TELCO, SEMIS

SES: a strong Q4 in line with last week's trading update

Sopra Steria Group : Déclaration du nombre d’actions et de droits de vote au 31 janvier 2025

SES: defying Moody’s downgrade with a FY24 pre-release

Nel: FY24 results, poor visibility FY25

SES: a strong Q4 in line with last week's trading update

Medincell: Uzedy's sNDA for label extension into BP-I accepted by the FDA

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe